Hester Biosciences Quarterly Results for Trading Insights
HESTERBIO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹14 Cr
QSept 2025
Hester Biosciences Quarterly Results Key Highlights
- Revenue of ₹83 Cr in Sept 2025 (+9.2% vs Mar 2025, -4.6% vs Sept 2024)
- Net Profit of ₹14 Cr in Sept 2025 (+600.0% vs Mar 2025, +75.0% vs Sept 2024)
- EBITDA of ₹24 Cr in Sept 2025 (+71.4% vs Mar 2025)
- Operating Margin of 17.0% in Sept 2025 (-6.0pp vs Mar 2025)
- Earnings Per Share of ₹16.85 in Sept 2025 (+825.8% vs Mar 2025)
Hester Biosciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 83 | 76 | 88 | 87 | 84 | 9.2% | -4.6% |
| Net Profit (₹ Cr) | 14 | 2 | 17 | 8 | 6 | - | - |
| EBITDA (₹ Cr) | 24 | 14 | 26 | 22 | 21 | - | - |
| EPS (₹) | 16.85 | 1.82 | 20.33 | 9.86 | 7.52 | - | - |
| Operating Margin (%) | 17.0% | 23.0% | 27.0% | 23.0% | 20.0% | - | - |
Hester Biosciences Share Price Trend Around Quarterly Results
Visualize Hester Biosciences's 1-year price movement across quarterly results — ideal for logging trades in Hester Biosciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Hester Biosciences
Additional stock information and data for HESTERBIO
Revenue Trend (₹ Cr)
Sept 2024
87
Jun 2025
88
Mar 2025
76
Sept 2025
83
Net Profit Trend (₹ Cr)
Sept 2024
8
Jun 2025
17
Mar 2025
2
Sept 2025
14
Operating Margin Trend (%)
Sept 2024
23.0%
Jun 2025
27.0%
Mar 2025
23.0%
Sept 2025
17.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Hester Biosciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores